Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3) Peptid

G2E3 Reaktivität: Human Wirt: Synthetic BP, WB
Produktnummer ABIN978925

Kurzübersicht für G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3) Peptid (ABIN978925)

Target

G2E3 (G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3))

Spezies

Human

Quelle

  • 1
Synthetic

Applikation

Blocking Peptide (BP), Western Blotting (WB)
  • Produktmerkmale

    This is a synthetic peptide designed for use in combination with anti-KIAA1333 antibody (Catalog #: ARP43228_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Aufreinigung

    Purified
  • Applikationshinweise

    Each Investigator should determine their own optimal working dilution for specific applications.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Lyophilized

    Rekonstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Konzentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handhabung

    Avoid repeated freeze-thaw cycles.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    G2E3 (G2/M-Phase Specific E3 Ubiquitin Protein Ligase (G2E3))

    Hintergrund

    KIAA1333 is a probable E3 ubiquitin-protein ligase which accepts ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfers the ubiquitin to targeted substrates.

    Alias Symbols: FLJ20333, G2E3, PHF7B, KIAA1333

    Protein Interaction Partner: LST1,WDR6,WDR6

    Protein Size: 706

    Molekulargewicht

    80 kDa

    Gen-ID

    55632

    NCBI Accession

    NM_017769, NP_060239

    UniProt

    Q7L622
Sie sind hier:
Chat with us!